| Authors: |
Michael P; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Blachman-Braun R; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Loebach L; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fu H; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Millan B; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Saini J; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Linehan WM; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ball M; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. mark.ball@nih.gov. |
